p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system

被引:74
作者
Xia, Meihui [1 ,2 ]
Yu, Huimei [3 ]
Gu, Shuang [4 ]
Xu, Ye [5 ]
Su, Jing [3 ]
Li, Hongyan [3 ]
Kang, Jinsong [3 ]
Cui, Manhua [1 ]
机构
[1] Jilin Univ, Hosp 2, Dept Obstet & Gynecol, Changchun 130041, Jilin, Peoples R China
[2] Jilin Univ, Hosp 1, Dept Obstet & Gynecol, Changchun 130021, Jilin, Peoples R China
[3] Jilin Univ, Sch Basic Med Sci, Dept Pathophysiol, Changchun 130021, Jilin, Peoples R China
[4] Peoples Hosp Jilin Prov, Dept Thorac Surg, Changchun 130021, Jilin, Peoples R China
[5] Jilin Med Coll, Med Res Lab, Jilin 132013, Peoples R China
基金
中国国家自然科学基金;
关键词
p62/SQSTM1; Keapl-Nrf2-ARE signaling pathway; apoptosis; cisplatin; drug resistance; ovarian cancer; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; OXIDATIVE STRESS; NRF2; CHEMOTHERAPY; P62;
D O I
10.3892/ijo.2014.2669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mechanisms underlying cisplatin resistance in tumors are not fully understood. Previous studies have reported that cellular resistance to oxidative stress is accompanied by resistance to cisplatin. However, the relationship between the resistance to oxidative stress and cisplatin drug resistance in human ovarian cancer cells (HOCCs) is not clear. Here, we reveal a critical role for the multifunctional protein p62/SQSTM1 in cisplatin resistance in human ovarian cancer cells (HOCCs). p62/SQSTM1 (sequestosome 1) plays important roles in cell differentiation, proliferation and as an antiapoptotic molecule. We found that cisplatin-resistant SKOV3/DDP cells express much higher levels of p62 than do cisplatin-sensitive SKOV3 cells. The protein p62 can activate the Keapl-Nrf2-ARE signaling pathway and induce the expression of antioxidant genes in SKOV3/DDP cells. Knockdown of p62 resensitizes SKOV3/DDP cells to cisplatin. Collectively, our data indicate that cisplatin resistance in HOCCs is partially attributable to their high expression of p62, which plays an important role in preventing ROS stress-induced apoptosis by regulating the Keapl-Nrf2-ARE signaling pathway.
引用
收藏
页码:2341 / 2348
页数:8
相关论文
共 50 条
[31]   p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis [J].
Jiang, Ganggang ;
Liang, Xue ;
Huang, Yiqiao ;
Lan, Ziquan ;
Zhang, Zhiming ;
Su, Zhengming ;
Fang, Zhiyuan ;
Lai, Yuxiong ;
Yao, Wenxia ;
Liu, Ting ;
Hu, La ;
Wang, Fen ;
Huang, Hai ;
Liu, Leyuan ;
Jiang, Xianhan .
ONCOLOGY REPORTS, 2020, 43 (05) :1547-1557
[32]   Comparative Analysis of the Mutation and Expression Profile of the Cytoprotective NRF2/KEAP1/P62/SQSTM1 Signaling Pathway in Different Glioma Subtypes: An In Silico Study [J].
Akin, Dilara Fatma ;
Aktas, Sedef Hande .
NAMIK KEMAL MEDICAL JOURNAL, 2023, 11 (01) :1-11
[33]   Dehydroepiandrosterone triggers autophagic cell death in human hepatoma cell line HepG2 via JNK-mediated p62/SQSTM1 expression [J].
Vegliante, Rolando ;
Desideri, Enrico ;
Di Leo, Luca ;
Ciriolo, Maria Rosa .
CARCINOGENESIS, 2016, 37 (03) :233-244
[34]   Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1 [J].
Granato, Marisa ;
Gilardini Montani, Maria Saveria ;
Angiolillo, Camilla ;
D'Orazi, Gabriella ;
Faggioni, Alberto ;
Cirone, Mara .
VIRUSES-BASEL, 2019, 11 (01)
[35]   Nrf2 and Parkin-Hsc70 regulate the expression and protein stability of p62/SQSTM1 under hypoxia [J].
Siswanto, Ferbian Milas ;
Mitsuoka, Yumi ;
Nakamura, Misato ;
Oguro, Ami ;
Imaoka, Susumu .
SCIENTIFIC REPORTS, 2022, 12 (01)
[36]   An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62 [J].
Foster, A. ;
Scott, D. ;
Layfield, R. ;
Rea, S. L. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 98 :32-45
[37]   Luteolin Exerts Neuroprotection via Modulation of the p62/Keap1/Nrf2 Pathway in Intracerebral Hemorrhage [J].
Tan, Xin ;
Yang, Yi ;
Xu, Jianguo ;
Zhang, Peng ;
Deng, Ruming ;
Mao, Yiguang ;
He, Jia ;
Chen, Yibin ;
Zhang, Yan ;
Ding, Jiasheng ;
Li, Haiying ;
Shen, Haitao ;
Li, Xiang ;
Dong, Wanli ;
Chen, Gang .
FRONTIERS IN PHARMACOLOGY, 2020, 10
[38]   Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway [J].
Guo, Yingying ;
Li, Dan ;
Cen, Xian-feng ;
Qiu, Hong-liang ;
Ma, Yu-lan ;
Liu, Yi ;
Huang, Si-hui ;
Liu, Li-bo ;
Xu, Man ;
Tang, Qi-Zhu .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
[39]   LLPS of SQSTM1/p62 and NBR1 as outcomes of lysosomal stress response limits cancer cell metastasis [J].
Noguchi, Takuya ;
Sekiguchi, Yuto ;
Shimada, Tatsuya ;
Suzuki, Wakana ;
Yokosawa, Takumi ;
Itoh, Tamaki ;
Yamada, Mayuka ;
Suzuki, Midori ;
Kurokawa, Reon ;
Hirata, Yusuke ;
Matsuzawa, Atsushi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (43)
[40]   NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway [J].
Wu, Qi ;
Zhang, Huijiang ;
You, Shengjie ;
Xu, Zhaoyu ;
Liu, Xiang ;
Chen, Xuedong ;
Zhang, Weili ;
Ye, Junjie ;
Li, Peng ;
Zhou, Xiaoqing .
ENVIRONMENTAL TOXICOLOGY, 2023, 38 (07) :1678-1689